Grindeks
Develops & manufactures pharmaceuticals for cardiovascular, CNS, cancer, and diabetes globally.
GRD1R | Nasdaq Baltic
Overview
Corporate Details
- ISIN(s):
- LV0000100659
- LEI:
- 5299006DWR32NKWM1O86
- Country:
- Latvia
- Address:
- Krustpils 53, LV-1057 Riga
- Website:
- https://grindeks.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Grindeks is an international, vertically integrated pharmaceutical company recognized as the leading pharmaceutical manufacturer in the Baltic States. Operating since 1946, the company's core activities encompass the research, development, manufacturing, and sales of original products, generics, and active pharmaceutical ingredients (APIs). Its product portfolio primarily focuses on medicines for the cardiovascular system, central nervous system, anti-cancer treatments, and diabetes. Grindeks is actively strengthening its global presence by expanding into new export markets worldwide.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Grindeks filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Grindeks via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
